Ken Griffin’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Buy |
+7,077
| New | +$255K | ﹤0.01% | 4780 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | -$14K | – | 6715 |
|
|
2022
Q3 | $14K | Sell |
1
-2
| -67% | -$28K | ﹤0.01% | 5594 |
|
|
2022
Q2 | $93K | Buy |
+3
| New | +$93K | ﹤0.01% | 5325 |
|
|
2022
Q1 | – | Hold |
0
| – | -$78K | – | 5879 |
|
|
2021
Q4 | – | Sell |
-1
| Closed | -$374K | – | 6024 |
|
|
2021
Q3 | $374K | Buy |
+1
| New | +$374K | ﹤0.01% | 4821 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | -$776K | – | 7099 |
|
|
2021
Q1 | $776K | Buy |
+1
| New | +$776K | ﹤0.01% | 4168 |
|
|
2020
Q4 | – | Hold |
0
| – | -$67K | – | 5583 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | -$270K | – | 4339 |
|
|
2020
Q2 | $270K | Buy |
+1
| New | +$270K | ﹤0.01% | 3875 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4508 |
|
|
2018
Q4 | – | Hold |
0
| – | -$22K | – | 4945 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4126 |
|
|
2017
Q2 | – | Hold |
0
| – | -$119K | – | 4173 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3298 |
|
|
2016
Q4 | – | Hold |
0
| – | -$151K | – | 4086 |
|
|
2016
Q3 | – | Hold |
0
| – | -$376K | – | 3118 |
|
|
2016
Q2 | – | Hold |
0
| – | -$458K | – | 2413 |
|
|
2016
Q1 | – | Hold |
0
| – | -$1.7M | – | 2272 |
|
|
2015
Q4 | – | Hold |
0
| – | -$1.09M | – | 1658 |
|
|
2015
Q3 | – | Hold |
0
| – | -$43K | – | 2109 |
|
|
2015
Q2 | – | Hold |
0
| – | -$36K | – | 3465 |
|
|
2015
Q1 | – | Hold |
0
| – | -$8K | – | 3444 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 3760 |
|
|
2014
Q2 | – | Hold |
0
| – | -$240K | – | 3731 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 2743 |
|